|
|||||
|
|
Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data |
|
| Authors: | Chakkarin Burudpakdee Huamao Mark Lin Weiying Wang Arpamas Seetasith Yanyan Zhu Vijayveer Bonthapally |
| Institution: | 1. IMS Health, Fairfax, VA, USA;2. University of North Carolina at Charlotte, Charlotte, NC, USA;3. Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;4. NucleusX Market Access, Warren, NJ, USA |
| Abstract: | |
| Keywords: | Peripheral T-cell lymphoma Claims analysis Cost of illness United States Health resources Hospitalization |